GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » Pre-Tax Income

OSTX (OS Therapies) Pre-Tax Income : $-7.36 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OS Therapies Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. OS Therapies's pretax income for the three months ended in Sep. 2024 was $-2.88 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $-7.36 Mil. OS Therapies's pretax margin was %.


OS Therapies Pre-Tax Income Historical Data

The historical data trend for OS Therapies's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OS Therapies Pre-Tax Income Chart

OS Therapies Annual Data
Trend Dec21 Dec22 Dec23
Pre-Tax Income
-7.42 -6.26 -7.79

OS Therapies Quarterly Data
Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.98 -1.47 -1.46 -1.56 -2.88

Competitive Comparison of OS Therapies's Pre-Tax Income

For the Biotechnology subindustry, OS Therapies's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OS Therapies's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OS Therapies's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where OS Therapies's Pre-Tax Income falls into.



OS Therapies Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

OS Therapies's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-4.343+0+-3.449+0+0
=-7.79

OS Therapies's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.437+0+-0.438+0+0
=-2.88

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OS Therapies  (AMEX:OSTX) Pre-Tax Income Explanation

OS Therapies's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-2.875/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OS Therapies Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of OS Therapies's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


OS Therapies Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
15825 Shady Grove Road, Suite 135, Rockville, MD, USA, 20850
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.